In Vitro Activities of Y-688, a New 7-Substituted Fluoroquinolone, against Anaerobic Bacteria
AUTOR(ES)
MacGowan, A. P.
FONTE
American Society for Microbiology
RESUMO
The in vitro activities of Y-688, a new 7-substituted fluoroquinolone derivative, against 317 nonduplicate anaerobic isolates were determined. Eighty-five percent of the Bacteroides fragilis group (n = 89) were inhibited by ≤2 mg of Y-688 per liter, while 78, 100, 89, and 98% of gram-negative bacilli (n = 135), gram-positive cocci (n = 59), and non-spore-forming (n = 58) and spore-forming (n = 51) gram-positive bacilli, respectively, were inhibited by ≤1 mg of Y-688 per liter.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=105425Documentos Relacionados
- In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp.
- In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae.
- Y-688, a New Quinolone Active against Quinolone-Resistant Staphylococcus aureus: Lack of In Vivo Efficacy in Experimental Endocarditis
- In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria.
- In Vitro Activity of BAY 12-8039, a New Fluoroquinolone, against Mycoplasmas